Year: 2020
Type: review
Abstract: Since its discovery twenty-five years ago, the fat-derived hormone leptin has provided a revolutionary framework for studying the physiological role of adipose tissue as an endocrine organ. Leptin exerts pleiotropic effects on many metabolic pathways and is tightly connected with the liver, the major player in systemic metabolism. As a consequence, understanding the metabolic and hormonal interplay between the liver and adipose tissue could provide us with new therapeutic targets for some chronic liver diseases, an increasing problem worldwide. In this review, we assess relevant literature regarding the main metabolic effects of leptin on the liver, by direct regulation or through the central nervous system (CNS). We draw special attention to the contribution of leptin to the non-alcoholic fatty liver disease (NAFLD) pathogenesis and its progression to more advanced stages of the disease as non-alcoholic steatohepatitis (NASH). Likewise, we describe the contribution of leptin to the liver regeneration process after partial hepatectomy, the mainstay of treatment for certain hepatic malignant tumors.
DOI: 10.3390/ijms21249368
Authors: Maite Martínez-Uña(Data curation, Writing – original draft, Writing – review & editing), Yaiza López-Mancheño(Data curation, Writing – original draft, Writing – review & editing), Carlos Diéguez(Writing – review & editing), Manuel A. Fernández-Rojo(Writing – review & editing), Marta G. Novelle(Conceptualization, Data curation, Supervision, Writing – original draft, Writing – review & editing)
Institutions: Madrid Institute for Advanced Studies, IMDEA Food, Universidade de Santiago de Compostela, Instituto de Salud Carlos III, Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition, Center for Research in Molecular Medicine and Chronic Diseases, Centro de Investigación Biomédica en Red, Instituto de Investigación Sanitaria de Santiago, The University of Queensland
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,112
Funders: Comunidad de Madrid, Ministerio de Ciencia, Innovación y Universidades, European Commission, Xunta de Galicia, Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición, Centro Singular de Investigación de Galicia, Instituto de Salud Carlos III, European Regional Development Fund, Agencia Estatal de Investigación
OpenAlex ID: W3112098306
